Spinal Bone Growth Stimulators Market To See Huge Growth In Forecast Year 2024-2030 | Cognate Life Sciences

The Latest Research Report on Spinal Bone Growth Stimulators Market 2024 outlines the key factors influencing the growth of this area in terms of the competitive and geographic environment. In addition, the research discusses the obstacles to market growth and provides information on unexplored prospects that will promote company progress in the 2024-2030 forecast period.

Get a sample PDF of the report in your inbox within 24 hours: https://www.cognatelifesciences.com/sample-request/2091/

Major Major Players are:
Orthofix US LLC, Stryker, Medical Device Business Services, Inc.,,  Bioventus, Medtronic,, DJO, LLC,,  Zimmer Biomet,, Arthrex, Inc.,, Terumo Corporation,, Ossatec Benelux BV.

Spinal Bone Growth Stimulators Market Overview:

Spinal Bone Growth Stimulators Market Analysis:

Bone growth and fusion in a surgically treated spinal segment can be stimulated by specialized medical devices called bone stimulators, which emit low-voltage electric currents. The newly formed bone grows in the interbody space and fuses the treated spinal segments. Bone stimulators can either be implanted (internal) or worn outside the body (external). There are 3 different types of electrical stimulation: Direct current stimulation, Pulsed electromagnetic field stimulation, Capacitive coupled electrical stimulation. Due to high costs and inconsistent results, only 32% of spine surgeons use bone stimulators to enhance spinal fusion in their patients.

The impact of COVID-19 on the studied market is expected to be significant. On one hand, due to the lockdown and travel restriction imposed to combat the transmission of the COVID-19 virus, incidences of road accidents and consequent fractures and injuries have reduced, which has highly impacted the studied market. On the other hand, as per a research article published in the Journal of Clinical Pharmacy and Therapeutics, 2020, the elderly population became more prone to bone fractures during the pandemic due to lack of out-of-home activities, sedentary lifestyle, and decreased exposure to sunlight and consequent Vitamin D deficiency. Additionally, as per a research study published in Bone and Joint Open, 2020, there was a significant increase in hip fractures, especially among the elderly population in the United Kingdom, during the pandemic, which was majorly attributed to the lack of caretakers and relatives to take care of the aged people. Thus, the increasing incidence of fractures and trauma cases among the elderly population during the pandemic turns the spotlight on the bone growth stimulators, in turn driving the growth of the studied market.. The bone growth stimulator market is majorly driven by factors such as the rising incidence of bone and joint disorders, growing demand for non-invasive and minimally invasive surgeries across the world, and the growing geriatrics population.

An increasing incidence of trauma and accident cases worldwide is considered as one of the major factors likely to boost the demand for the studied market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, given the aforementioned factors, the bone growth stimulator market is expected to witness significant growth over the forecast period globally. The rising incidence of age-related disorders (such as rheumatoid arthritis, osteoarthritis, osteoporosis, and fractures) and sports injuries drives the demand for non-invasive and minimally invasive surgical treatments worldwide.

Minimally invasive therapeutic procedures are increasingly being preferred owing to their benefits, such as painless treatment, reduced postoperative hospital stay, reduced surgical trauma, limited tissue scarring, reduced surgical risks, improved patient care, shorter postoperative recovery periods, and greater affordability. These procedures are used for a broad range of spinal disorders, such as spondylosis/spondylolisthesis, stenosis, pseudarthrosis, fractures, trauma, and bone healing.

In February 2020, Orthofix Medical Inc. received US FDA approval for its STIM on Track, mobile app version 2.1 to advance the treatment with its bone growth stimulators such as CervicalStim, SpinalStim, and PhysioStim.

In January 2020, Medtronic acquired Stimgenics to expand its portfolio in the Differential Target Multiplexed Spinal Cord Stimulation Therapy.

Spinal Bone Growth Stimulators Market Trends:

The spinal bone growth stimulators market is subject to several notable trends that are shaping the industry and influencing the development and adoption of these devices. The field of bone growth stimulation is constantly evolving, with ongoing technological advancements leading to the development of more sophisticated and effective devices. This includes the integration of advanced materials, sensors, and patient monitoring technologies. There is a growing trend toward minimally invasive spinal surgeries, and this trend is driving the use of bone growth stimulators that can be used in conjunction with less invasive procedures. These devices are designed to minimize tissue disruption and speed up the recovery process.

Device manufacturers are increasingly focusing on patient-centric design, making bone growth stimulators more user-friendly and convenient for patients. This includes devices that are wearable, portable, and comfortable for extended use. External bone growth stimulators designed for home use are becoming more prevalent. These devices allow patients to continue treatment outside of clinical settings, improving compliance and patient outcomes. Physicians are exploring the use of bone growth stimulators in combination with other treatment modalities, such as regenerative medicine and pharmaceuticals, to enhance healing and fusion outcomes. Tailoring treatment to the individual patient is becoming more common. Personalized treatment plans, including the use of bone growth stimulators, may improve the overall success of spinal fusion and fracture healing. The use of remote monitoring and telehealth technologies has become increasingly important, allowing healthcare providers to track patient progress and ensure compliance with treatment regimens.

The external bone growth stimulators are expected to witness a significant market share over the forecast period. The advanced features of external bone growth stimulators, namely their light weight, ease of handling, and portability, act as a major driver for the growth of the current segment.

According to the research study published in Bone and Joint Open, 2020, in 2020, there was an increase in fractures and minor injuries requiring surgery among elderly patients during the COVID-19 lockdown in the United Kingdom, as compared to 2019. Though there was an increase in minor injuries requiring minor surgeries, the numbers of polytrauma and open fractures were reduced during the COVID-19 era due to a reduction in road traffic and in participation in outdoor sports activities. Thus, COVID-19 is expected to impact the studied market significantly during the pandemic era.

The demand for these products is increasing due to the rising number of bone fracture cases and the effectiveness of the external bone growth stimulators in healing fractures. According to a research article published in the Archives of Osteoporosis, 2020, fragility fractures in the largest five countries of the European Union plus Sweden (EU6) accounted for 2.7 million in 2017, and is expected to reach 3.3 million in 2030, which is a 23% increase from 2017. Additionally, as per the research study published in the Orthopedic Trauma Association International, 2020,14% of the Australian population have osteoporosis and 60,000 hip fractures have been estimated to occur by 2050 in Australia. This indicates the rising burden of fracture across the world. Therefore, there is a growing demand for external bone growth stimulators, which will contribute to the growth of the market for the same over the forecast period.

Get a Impressive Discount on corporate email id @ https://www.cognatelifesciences.com/discount-request/2091/

Market Segmentation are:
by Type of Stimulators (Implantable Bone Growth Stimulators, External Bone Growth Stimulators), by Application (Degenerative Disc Disease, Spinal Fusion, Facture Healing), by End Users (Hospitals, Ambulatory surgical centres (ASCs) , Home Care, Orthopaedic Centre), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa): Global Opportunity Analysis and Industry Forecast, 2023-2031

Spinal Bone Growth Stimulators insights, overview and deep study of factors are considered to have greater influence over future course of the industry such as market size, market share, different dynamics of the industry, Spinal Bone Growth Stimulators market companies, regional analysis of the domestic markets, value chain analysis, consumption, demand, key application areas and more.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

How will this report benefit potential stakeholders?
-Comprehensive assessment of all opportunities and risks in the Spinal Bone Growth Stimulators market.
-The detailed study of business strategies for the growth of the Spinal Bone Growth Stimulators market-leading players.
-Conclusive study about the growth plot of the Spinal Bone Growth Stimulators market for forthcoming years.
-In-depth understanding of Spinal Bone Growth Stimulators market-particular drivers, constraints, and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the Spinal Bone Growth Stimulators market.

Any Questions? Feel Free To Enquire Here. Well put you on the Right Path @ https://www.cognatelifesciences.com/enquiry-request/2091/

What Spinal Bone Growth Stimulators Market report offers:
1.Spinal Bone Growth Stimulators Market share assessments for the regional and country-level segments
2.Market share analysis of the top industry players
3.Spinal Bone Growth Stimulators Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
4.Strategic recommendations in key business segments based on the market estimations
5.Competitive landscape covering following points: Company Overview, Product Portfolio, Financial Performance, Recent Highlights, Strategies

COVID-19 has had a major impact on the world economy in addition to that on the public health. This particular pandemic had caused severe economic destruction and not a single country has been left unaffected. The virus has forced businesses around the globe to change the way they operate. This report gives an analysis of the COVID-19 aftermath on Spinal Bone Growth Stimulators market.

Competitive Rivalry:
The report highlights vital details based on the leading players in the global Industrial Spinal Bone Growth Stimulators market. It features their details such as product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, manufacturing base, capacities, production volume, major vendors, raw material sourcing strategies, organizational structure. Their latest corporate deals, joint ventures, mergers and acquisitions, product launches, and other brand promotions are other facts about the market players included in the report.

We also offer customization on reports based on specific client requirement:
1- country-level analysis for any 5 countries of your choice.
2- Competitive analysis of any market players.
3- 40 analyst hours to cover any other data points

Purchase this report now @ https://www.cognatelifesciences.com/buy-now/?id=2091&license_type=su

Finally, Spinal Bone Growth Stimulators Market is a valuable source of guidance for individuals and companies in decision framework.

Contact Us:
Robin McKay
Client Partner Relations
USA/Canada(Toll Free): 1800-601-6071
Mail: sales@cognatelifesciences.com
Web: www.cognatelifesciences.com

About us :

Cognate Lifesciences is a specialized hub for all market research reports related to Lifesciences Market. Some of the sub domains covered by our team are Pharmaceuticals, Medical Devices and Supplies, Healthcare, Diagnostics, Biotech, Therapeutics, Healthcare IT etc. We offer syndicated/customized market research studies along with advisory and consulting services.

This release was published on openPR.